Boston Scientific Corp. has received clearance from the U.S. Food and Drug Administration for its new device designed to make kidney stone procedures safer and easier. The Marlborough company ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Marlborough, Mass. Boston Scientific Corporation today announced the European launch of the LithoVue™ Single-Use Digital Flexible Ureteroscope for minimally invasive endoscopic procedures to diagnose ...

Boston Scientific launched a new kidney stone retrieval device that allows a single urologist to operate both a ureteroscope and a basket simultaneously during the procedure, performed via flexible ...

Contaminated endoscopes are a persistent problem for the medical device industry and its regulators. Not only is it difficult for hospitals to reprocess or sterilize all sorts of endoscopes ...

(RTTNews) - Boston Scientific Corp. (BSX) said Friday that it has received a 510(k) clearance from the U.S. Food and Drug Administration for the LithoVue Elite Single-Use Digital Flexible Ureteroscope ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA granted 510(k) clearance to Boston Scientific ...

Boston Scientific CorporationBSX recently launched its new urology device globally. Called LithoVue Empower Retrieval Deployment Device, it will be used together with the LithoVue Single-Use Digital ...

MARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single-Use ...

Boston Scientific Corporation BSX recently launched its new urology device globally. Called LithoVue Empower Retrieval Deployment Device, it will be used together with the LithoVue Single-Use Digital ...